Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Post by prophetoffactzon Jun 11, 2024 10:16pm
77 Views
Post# 36083986

Advantages of Avenanthramides over NSAIDs

Advantages of Avenanthramides over NSAIDsAvenanthramides, compounds found in oats, exhibit potent anti-inflammatory properties that may offer advantages over traditional non-steroidal anti-inflammatory drugs (NSAIDs). Here are the key points:

Advantages of Avenanthramides over NSAIDs

  • Avenanthramides inhibit the production of pro-inflammatory mediators like IL-6, IL-8, MCP-1, and adhesion molecules (ICAM-1, VCAM-1, E-selectin) by suppressing NF-κB activation, a key pathway in inflammation. NSAIDs primarily inhibit cyclooxygenase enzymes.
  • Avenanthramides target multiple inflammatory pathways, including NF-κB, JNK, and p38 kinase, providing a broader anti-inflammatory effect. NSAIDs mainly target cyclooxygenase enzymes.
  • Avenanthramides have been shown to inhibit the expression and activity of matrix metalloproteinases (MMPs) like MMP-3, MMP-12, and MMP-13, which play a crucial role in cartilage degradation in osteoarthritis. NSAIDs do not directly target MMPs.
  • Avenanthramides are natural compounds derived from oats, potentially offering a safer alternative to synthetic NSAIDs, which can cause gastrointestinal side effects like ulcers and bleeding.

Potential Limitations

  • Avenanthramides are relatively new compounds, and their long-term safety and efficacy in humans need further investigation.
  • The bioavailability and optimal dosing of avenanthramides for therapeutic purposes are still being studied.
In summary, avenanthramides exhibit multi-targeted anti-inflammatory mechanisms that may provide advantages over traditional NSAIDs in treating inflammatory conditions like osteoarthritis. However, more research is needed to fully establish their clinical utility and safety profile.
<< Previous
Bullboard Posts
Next >>